The global MIVCF treatment device market will be driven mainly by the growing aging and obese population across the globe. Furthermore, new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see moderate growth through 2027. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCF treatment devices in the global region across a 10-year period.


Large MNCs continue to dominate the moderately expanding global MIVCF treatment market, bolstering share through mergers and acquisitions and product launches. 

Which competitors lead the MIVCF treatment market globally, and what factors contribute to their success in this space?

What strategies can local and international players implement to capture share in the global MIVCF treatment market?

What types of mergers and acquisitions have occurred in recent years, and how do they affect market shares?

There have been few product launches in the vertebroplasty market.

What factors are contributing to a lack of manufacturer focus in the vertebroplasty market?

What can companies competing in the vertebroplasty market do to maintain or gain shares?

Several studies and reports are showing vertebroplasty and vertebral augmentation to be not beneficial in treating VCFs.

What are physicians' opinion on this?

How have these findings affected the global MIVCF treatment market?

Table of contents

  • Global
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • MIVCF Treatment Market
      • Market Highlights
        • US
        • Europe
        • Asia Pacific
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Reimbursement
        • Pricing Strategies and Purchasing Options
        • Mergers, Acquisitions, and Partnerships
        • Physician Training and Marketing
        • First-Mover Advantage
        • Product Improvements and Innovations
      • Market Developments
    • Vertebroplasty Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Vertebral Augmentation Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Monica Lin, BSc

Monica Lin is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, focusing on the sports medicine, spinal implant, vertebral compression fracture treatment, and skin replacement and substitute markets. Monica holds an Honors Bachelor's degree in Life Physics and Economics from the University of Waterloo.


Related Reports

Trauma Devices | Medtech 360 | Market Insights | Europe

The European trauma device market will see modest growth through 2027. Financial constraints and the increasing presence of GPOs will, however,...

View Details

Orthotic Devices | Medtech 360 | Market Insights | United States

Despite a changing and challenging reimbursement landscape, the US market for orthotic devices will continue to grow at a modest rate through 2027, primarily driven by favorable demographics, in...

View Details

Spinal Implants | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

Favorable demographics and increased access to health care in some of the countries covered will support procedure volume expansion, driving growth in the Asia Pacific spinal implant market thro...

View Details

Spinal Implants | Medtech 360 | Market Insights | Europe (Supplemental)

The European spinal implant market will see modest growth through 2027, driven by relatively high spending on health care and physician training, a growing elderly populat...

View Details